{"id":2278,"date":"2017-06-02T00:00:00","date_gmt":"2017-06-02T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.comindex.php\/2017\/06\/02\/pinup060217\/"},"modified":"2019-02-06T02:14:42","modified_gmt":"2019-02-06T02:14:42","slug":"pinup060217","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/articles\/news\/pinup060217\/","title":{"rendered":"PinUp: Pharma’s Reputation, Patient Centricity, and the Civil War Over the Price of Drugs, More…"},"content":{"rendered":"

Pharma Industry News Update<\/b>: 2 June 2017<\/p>\n\n

Patient Centricity & Pharma’s Reputation Patient Centricity used to be a buzzword in that it was often mentioned but seldom practiced by pharma companies. A lot of progress has been made in the past years to achieve patient centricity, but not all drug companies have had much success. Unfortunately, that has had a negative impact on the industry’s reputation. <\/p>\n

Top 10 Most Reputable Pharma Companies
According to “Friendly” Public Segment<\/p>\n

<\/p>\n

[From pharmamkting.blogspot.com<\/a>] Depending on who you ask, the drug industry’s reputation is at an all-time low (read, for example, “Pharma’s Rep Among Patient Groups Sinks to Near Historical Lows<\/a>“) or an all-time high!<\/p>\n

For example, if you determine the reputation of a pharma company measured by “the general public who are somewhat or very familiar with the company,” then that company’s reputation is likely to score much higher than if you asked the general public whose “familiarity” with the company is not a factor.<\/p>\n

Such is the case with the latest Reputation Institute ranking, which was said to be based on the opinions of the “general public.” Later in the fine print of the PR, you learn what they measured are\u00a0the attitudes of only a segment of the general public – those who are “familiar” with the companies.<\/p>\n

More here…<\/a><\/p>\n

Further Reading:<\/b><\/p>\n